Rochester, Minn.-based Mayo Clinic recorded an income from current activities of $380 million (7.1% margin) in the second quarter of 2025 quarter, down from $449 million (8.9% margin) during the same period last year, according to its Aug. 18 financial report.
Total operating revenue was $5.3 billion for the three months ended June 30, up from $5 billion during the same period last year. Mayo’s net patient service revenue was $4.5 billion, an 8.6% increase year over year. The system attributed the growth to strong outpatient, surgical and hospital volumes, as well as increased service demand.
Contributions available for operating activities was $73 million in the quarter, down from $115 million during the same period last year. Mayo Clinic attributed the decrease to a greater portion of total giving being directed to nonoperating activities, such as endowments and capital projects.
Total operating expenses were $5 billion in the quarter, up from $4.6 billion during the same period last year. Salaries and benefits — totaling $2.8 billion — increased 7.5% year over year and accounted for 56.3% of total expense. Supply and service expenses were $1.8 billion, a 10.8% increase year over year.
As of June 30, Mayo Clinic had 361 days cash on hand, compared to 362 on Dec. 31. The system had a long-term debt of $5 billion as of the end of the second quarter, up from $4.6 billion on Dec. 31.
Mayo Clinic reported a net income of $1.1 billion in the second quarter, up from $613 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
